Lantheus Holdings, Inc. (LNTH)

66.71 +0.18 (+0.27%) USD  |  NASDAQ  |  Dec 24, 12:59
66.73 +0.02 (+0.03%) After-Hours: 13:59
More

Lantheus Holdings SG&A Expense (TTM): 439.11M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for LNTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Cytokinetics, Inc. 254.89M
Integra LifeSciences Holdings Corp. 708.95M
Iovance Biotherapeutics, Inc. 158.68M
Tandem Diabetes Care, Inc. 437.73M
Day One Biopharmaceuticals, Inc. 116.18M